REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 480 filers reported holding REPLIGEN CORP in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,425,048 | +11.5% | 8,962 | -0.8% | 0.02% | +11.8% |
| Q2 2023 | $1,277,667 | -30.6% | 9,032 | -17.4% | 0.02% | -37.0% |
| Q1 2023 | $1,841,690 | -1.2% | 10,939 | -0.6% | 0.03% | -10.0% |
| Q4 2022 | $1,863,257 | -2.0% | 11,005 | +8.3% | 0.03% | -18.9% |
| Q3 2022 | $1,901,000 | +15.2% | 10,160 | -0.0% | 0.04% | +12.1% |
| Q2 2022 | $1,650,000 | -20.3% | 10,162 | -7.7% | 0.03% | -2.9% |
| Q1 2022 | $2,071,000 | -29.8% | 11,010 | -1.2% | 0.03% | -26.1% |
| Q4 2021 | $2,950,000 | -8.3% | 11,139 | +0.1% | 0.05% | -24.6% |
| Q3 2021 | $3,216,000 | +39.4% | 11,127 | -3.7% | 0.06% | +45.2% |
| Q2 2021 | $2,307,000 | +4.7% | 11,554 | +1.9% | 0.04% | -10.6% |
| Q1 2021 | $2,204,000 | +4.4% | 11,338 | +2.9% | 0.05% | +2.2% |
| Q4 2020 | $2,111,000 | +30.6% | 11,017 | +0.5% | 0.05% | +15.0% |
| Q3 2020 | $1,617,000 | +35.0% | 10,961 | +13.1% | 0.04% | +29.0% |
| Q2 2020 | $1,198,000 | – | 9,694 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |